Cardiac Mortality among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study

Circulation

Volumn 134, Issue 20, 2016, Pages 1519-1531

  Henson, Katherine E ^a   Reulen, Raoul C ^b   Winter, David L ^b   Bright, Chloe J ^b   Fidler, Miranda M ^b   Frobisher, Clare ^b   Guha, Joyeeta ^b   Wong, Kwok F ^b   Kelly, Julie ^b   Edgar, Angela B ^c   McCabe, Martin G ^d   Whelan, Jeremy ^e   Cutter, David J ^a,f   Darby, Sarah C ^a,f   Hawkins, Mike M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e and University of Bristol   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adolescent; cardiac deaths; epidemiology; heart diseases; mortality; neoplasms

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; BLADDER CANCER; BONE TUMOR; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; CARDIAC PATIENT; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM TUMOR; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENGLAND; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HODGKIN DISEASE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MIDDLE AGED; MORTALITY RISK; NONHODGKIN LYMPHOMA; OVARY CANCER; PERICARDIAL DISEASE; PRIMARY TUMOR; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; STANDARDIZED MORTALITY RATIO; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; VALVULAR HEART DISEASE; WALES; YOUNG ADULT; MORTALITY; NEOPLASM; RISK FACTOR; SURVIVOR; TIME FACTOR;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; NEOPLASMS; RISK FACTORS; SURVIVORS; TIME FACTORS; YOUNG ADULT;

EID: 84994762044     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.022514     Document Type: Article

References (32)

1. Thomas DM, Albritton KH, Ferrari A. Adolescent and young adult oncology: An emerging field. J Clin Oncol. 2010;28:4781-4782. doi: 10. 1200/JCO. 2010. 30. 5128.
2. Desandes E, Lacour B, Belot A, Molinie F, Delafosse P, Tretarre B, Velten M, Sauleau EA, Woronoff AS, Guizard AV, Ganry O, Bara S, Grosclaude P, Troussard X, Bouvier V, Brugieres L, Clavel J. Cancer incidence and survival in adolescents and young adults in France, 2000-2008. Pediatr Hematol Oncol. 2013;30:291-306. doi: 10. 3109/08880018. 2012. 762569.
3. Pollock BH, Birch JM. Registration and classification of adolescent and young adult cancer cases. Pediatr Blood Cancer. 2008;50(5 suppl):1090-1093. doi: 10. 1002/pbc. 21462.
4. Stock W, La M, Sanford B, Bloomfield CD, Vardiman JW, Gaynon P, Larson RA, Nachman J; Children's Cancer Group; Cancer and Leukemia Group B studies. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112:1646-1654. doi: 10. 1182/ blood-2008-01-130237.
5. Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack BJ, Sundar H, Shead DA. Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2012;10:1112-1150.
6. Tonorezos ES, Oeffinger KC. Research challenges in adolescent and young adult cancer survivor research. Cancer. 2011;117(10 suppl):2295-2300. doi: 10. 1002/cncr. 26058.
7. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B; Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288-298. doi: 10. 1038/nrc2349.
8. Fernandez CV, Barr RD. Adolescents and young adults with cancer: An orphaned population. Paediatr Child Health. 2006;11:103-106.
9. Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, Skinner R, Stevens MC, Hawkins MM; British Childhood Cancer Survivor Study Steering Group. Long-term causespecific mortality among survivors of childhood cancer. JAMA. 2010;304:172-179. doi: 10. 1001/jama. 2010. 923.
10. Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC. Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2328-2338. doi: 10. 1200/JCO. 2008. 21. 1425.
11. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. The Lancet. 2005; 365: 1687-717. doi: 10. 1016/S0140-6736(05)66544-0.
12. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. The Lancet. 2005;366:2087-2106. doi: 10. 1016/S0140-6736(05)67887-7.
13. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister A, Radford JA, Rohatiner AZ, Linch DC. Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst. 2007;99:206-214. doi: 10. 1093/jnci/djk029.
14. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21:3431-3439. doi: 10. 1200/JCO. 2003. 07. 131.
15. Prasad PK, Signorello LB, Friedman DL, Boice JD Jr, Pukkala E. Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer. 2012;58:421-427. doi: 10. 1002/pbc. 23296.
16. Kero AE, Järvelä LS, Arola M, Malila N, Madanat-Harjuoja LM, Matomäki J, Lähteenmäki PM. Late mortality among 5-year survivors of early onset cancer: A population-based register study. Int J Cancer. 2015;136:1655-1664. doi: 10. 1002/ijc. 29135.
17. Rugbjerg K, Mellemkjaer L, Boice JD, Køber L, Ewertz M, Olsen JH. Cardiovascular disease in survivors of adolescent and young adult cancer: A Danish cohort study, 1943-2009. J Natl Cancer Inst. 2014; 106: dju110.
18. van Laar M, Feltbower RG, Gale CP, Bowen DT, Oliver SE, Glaser A. Cardiovascular sequelae in long-term survivors of young peoples' cancer: A linked cohort study. Br J Cancer. 2014;110:1338-1341. doi: 10. 1038/bjc. 2014. 37.
19. Kero AE, Järvelä LS, Arola M, Malila N, Madanat-Harjuoja LM, Matomäki J, Lähteenmäki PM. Cardiovascular morbidity in long-term survivors of early-onset cancer: A population-based study. Int J Cancer. 2014;134:664-673. doi: 10. 1002/ijc. 28385.
20. Brewster DH, Clark D, Hopkins L, Bauer J, Wild SH, Edgar AB, Wallace WH. Subsequent hospitalisation experience of 5-year survivors of childhood, adolescent, and young adult cancer in Scotland: A population based, retrospective cohort study. Br J Cancer. 2014;110:1342-1350. doi: 10. 1038/bjc. 2013. 788.
21. Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, Stevens MC, Jenney M. The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50:1018-1025. doi: 10. 1002/ pbc. 21335.
22. Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006;106:1425-1430. doi: 10. 1002/cncr. 21773.
23. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer. 2002;87:1267-1274. doi: 10. 1038/sj. bjc. 6600647.
24. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC scientific publications. 1987;82:1-406.
25. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
26. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987-998. doi: 10. 1056/NEJMoa1209825.
27. Cutter DJ, Taylor CW, Rahimi K, McGale P, Ferreira V, Darby SC. Effects of radiation therapy on the cardiovascular system. In: Ewer MS, Yeh ET. Cancer and the Heart. 2nd ed. Hamilton, ON, Canada: BC Decker; 2013.
28. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290:2831-2837. doi: 10. 1001/jama. 290. 21. 2831.
29. Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD, Janus CP, van Leeuwen FE, Aleman BM. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. 2015;107:. doi: 10. 1093/jnci/djv008.
30. Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, Jones A. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010;10:337. doi: 10. 1186/1471-2407-10-337.
31. Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, Stovall M, Chow EJ, Sklar CA, Mulrooney DA, Mertens AC, Border W, Durand JB, Robison LL, Meacham LR. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673-3680. doi: 10. 1200/JCO. 2013. 49. 3205.
32. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van 't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, Bartelink H, van Leeuwen FE. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109:1878-1886. doi: 10. 1182/blood-2006-07-034405.